Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy
This study characterized estrogen and progesterone receptor expression in adenomyosis, finding upregulated mPRα, mPRβ, and ERβ, and confirmed estradiol increases cell proliferation while progesterone affects prolactin secretion.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (60)
- Adenomyosis and Infertility—Review of Medical and Surgical Approaches via openalex
- Adenomyosis and its impact on women fertility. via openalex
- Adenomyosis: a systematic review of medical treatment via openalex
- Adenomyosis: Mechanisms and Pathogenesis via openalex
- Adenomyosis: the pathophysiology of an oestrogen-dependent disease via openalex
- Alterations in progesterone receptor membrane component 2 (PGRMC2) in the endometrium of macaques afflicted with advanced endometriosis via openalex
- A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR) via openalex
- Anti-inflammatory cytokines in endometriosis via openalex
- Current and Prospective Treatment of Adenomyosis via openalex
- Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis via openalex
- Estrogen biosynthesis in human uterine adenomyosis via openalex
- Expression of Aromatase Cytochrome P450 Protein and Messenger Ribonucleic Acid in Human Endometriotic and Adenomyotic Tissues but not in Normal Endometrium1 via openalex
- Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis via openalex
- Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study via openalex
- Expression Patterns of Progesterone Receptor Membrane Components 1 and 2 in Endometria From Women With and Without Endometriosis via openalex
- Functional Expression of FSH Receptor in Endometriotic Lesions via openalex
- G Protein-Coupled Estrogen Receptor (GPER) Expression in Normal and Abnormal Endometrium via openalex
- Identifying Common Pathogenic Features in Deep Endometriotic Nodules and Uterine Adenomyosis via openalex
- Mechanisms of Development of Prolactin-Induced Adenomyosis in Mice via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Phenotypic Characterisation of the Inner and Outer Myometrium in Normal and Adenomyotic Uteri via openalex
- Possible roles of oxytocin receptor and vasopressin-1α receptor in the pathomechanism of dysperistalsis and dysmenorrhea in patients with adenomyosis uteri via openalex
- Progesterone Actions and Resistance in Gynecological Disorders via openalex
- Prolactin role in the bovine uterus during adenomyosis via openalex
- Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Adenomyosis and Its Rectification by a Histone Deacetylase Inhibitor and a Demethylation Agent via openalex
- Role of Estrogen Receptor-β in Endometriosis via openalex
- Serum prolactin and CA 125 levels in uterine adenomyosis via openalex
- The Genetic Background of Endometriosis: Can ESR2 and CYP19A1 Genes Be a Potential Risk Factor for Its Development? via openalex
- The induction of adenomyosis in mice by intrauterine pituitary isografts via openalex
- The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology via openalex
- The new application of mifepristone in the relief of adenomyosis-caused dysmenorrhea via openalex
- Uterine adenomyosis and adenomyoma: the surgical approach via openalex
- Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists via openalex
- W2339034515 via openalex
- W2169670549 via openalex
- W2147833624 via openalex
- W2612774447 via openalex
- W2783187175 via openalex
- W2116629267 via openalex
- W2114557980 via openalex
- W2099540110 via openalex
- W2951510639 via openalex
- W2083847763 via openalex
- W3043023573 via openalex
- W2052497884 via openalex
- W2038354928 via openalex
- W2036895536 via openalex
- W3094320124 via openalex
- W2031693308 via openalex
- W2023946729 via openalex
- W3159912251 via openalex
- W2019792229 via openalex
- W2006494078 via openalex
- W2002351432 via openalex
- W3210890914 via openalex
- W1999410340 via openalex
- W4214582077 via openalex
- W6667966913 via openalex
- W6678913744 via openalex
- W6681687428 via openalex
Cited by (12)
- Research Progress of Traditional Chinese Medicine in the Treatment of Adenomyosis-Related Signaling Pathways 2026
- Shared Biology Underlying Benign Endometrial Diseases and Endometrial Cancer: Current Knowledge and Future Prospectives 2026
- Improved surgical outcomes in adenomyosis: a novel insight into the superiority of secretory phase adenomyomectomy 2025
- Significance of diminished hormone expression in nulligravida woman presenting with triad of uterine pathologies 2025
- Hormone receptor profile of ectopic and eutopic endometrium in adenomyosis: a systematic review 2025
- Adenomyosis and endometrial cancer: determining its role as a biological contributor or incidental coexistence 2025
- Endometrial Stem Cells: Orchestrating Dynamic Regeneration of Endometrium and Their Implications in Diverse Endometrial Disorders 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- The pathogenesis of adenomyosis and its impact on fertility: a literature review 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- Establishment of an immortalized cell line derived from human adenomyosis ectopic lesions 2023
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-06-04T00:34:36.779044+00:00